Neema Shekhar, Banerjee D, Radhakrishnan S, Vasudevan Biju, Sinha Preema, Oberoi Bhavni
Department of Dermatology, Armed Forces Medical College, Pune, Maharashtra, India.
Department of Gastroenterology, Command Hospital, Kolkata, West Bengal, India.
Indian Dermatol Online J. 2020 May 10;11(3):387-390. doi: 10.4103/idoj.IDOJ_312_19. eCollection 2020 May-Jun.
The risk of liver damage in psoriasis increases with increase in cumulative dose of methotrexate and guidelines suggest use of liver biopsy for risk mitigation. Recently, transient elastography (TE) has been used for detection of liver fibrosis. Most studies for TE are in hepatitis B and C patients. However, psoriasis patients have risk factors like metabolic syndrome which predisposes them to increased risk of liver damage due to methotrexate. This underlying liver disease may change the TE values in patients with psoriasis. The aim of this study is to determine utility of transient elastography in detection of liver fibrosis in patients with psoriasis.
82 patients with chronic plaque psoriasis requiring systemic therapy or already on methotrexate were included in the study. Clinical examinationand biochemical investigations were conducted. Data were analysed using STATA 12.1 (Texas, USA). Univariate analysis using Chi-square and independent'-test' was carried out to evaluate the association between categorical variables and outcomes.
Patients consists of 62 males and 20 females. TE value >7 kPa (kilopascal) were seen in 23 patients and <7 kPa were seen in 59 patients. Value of >7 kPa was significantly associated with age, waist circumference, diastolic blood pressure, fasting and post prandial blood sugar, AST, PASI and presence of metabolic syndrome. Cumulative methotrexate dose was not significantly associated with high TE value. Mean TE value in patients with metabolic syndrome was significantly higher.
Small sample size and inability to confirm TE findings on liver biopsy.
TE is a non-invasive tool for detection of liver fibrosis. Value of >7 kPa correlates with liver fibrosis in most chronic liver diseases. However, high prevalence of metabolic syndrome in psoriasis patientsmayconfound utility of TE for monitoring of methotrexate toxicity.
银屑病患者肝损伤风险随甲氨蝶呤累积剂量的增加而升高,指南建议采用肝活检来降低风险。最近,瞬时弹性成像(TE)已用于肝纤维化检测。大多数关于TE的研究针对的是乙肝和丙肝患者。然而,银屑病患者存在代谢综合征等风险因素,这使他们因甲氨蝶呤而面临更高的肝损伤风险。这种潜在的肝脏疾病可能会改变银屑病患者的TE值。本研究的目的是确定瞬时弹性成像在检测银屑病患者肝纤维化中的效用。
82例需要全身治疗或已在使用甲氨蝶呤的慢性斑块状银屑病患者纳入本研究。进行了临床检查和生化检查。使用STATA 12.1(美国得克萨斯州)分析数据。采用卡方检验和独立样本t检验进行单因素分析,以评估分类变量与结果之间的关联。
患者包括62名男性和20名女性。23例患者的TE值>7千帕(kPa),59例患者的TE值<7 kPa。TE值>7 kPa与年龄、腰围、舒张压、空腹和餐后血糖、谷草转氨酶、银屑病面积和严重程度指数(PASI)以及代谢综合征的存在显著相关。甲氨蝶呤累积剂量与高TE值无显著关联。代谢综合征患者的平均TE值显著更高。
样本量小,且无法通过肝活检证实TE检查结果。
TE是一种用于检测肝纤维化的非侵入性工具。在大多数慢性肝病中,>7 kPa的数值与肝纤维化相关。然而,银屑病患者中代谢综合征的高患病率可能会混淆TE在监测甲氨蝶呤毒性方面的效用。